Skip to main content

Table 6 Age’s distribution and osteoporosis among CFTR mutation groups

From: Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study

Pancreatic status

Groups

N

Mean (months)

Standard deviation

Confidential interval

Minimum (months)

Maximum (months)

p-value

Osteoporosis (N/%)

p-value

5%

95%

 

No mutation identified

44

211.75

217.501

145.62

277.88

25

932

 

8 (19%)

 

Pancreatic insufficiency + Pancreatic sufficiency

One CFTR mutation identified

51

201.18

165.050

154.76

247.60

11

782

0.854

9 (17.6%)

 
 

Two mutation identified

84

220.06

188.643

179.12

261.00

7

1274

 

12 (14.3%)

0.761

Pancreatic insufficiency

One CFTR mutation identified

35

221.57

216.17

147.31

295.83

25

932

 

7 (21.2%)

 

Two mutation identified

43

198.81

171.31

146.09

251.54

11

782

0.940

5 (11.6%)

0.345

  1. CFTR, Cystic fibrosis transmembrane regulator; N, number of patients.